Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
J Am Chem Soc ; 146(14): 10044-10051, 2024 Apr 10.
Artículo en Inglés | MEDLINE | ID: mdl-38557014

RESUMEN

The electrochemical NO reduction reaction (NORR) is a promising approach for both nitrogen cycle regulation and ammonia synthesis. Due to the relatively low concentration of the NO source and poor solubility of NO in solution, mass transfer limitation is a serious but easily overlooked issue. In this work, porous carbon-supported ultrafine Cu clusters grown on Cu nanowire arrays (defined as Cu@Cu/C NWAs) are prepared for low-concentration NORR. A high Faradaic efficiency (93.0%) and yield rate (1180.5 µg h-1 cm-2) of ammonia are realized on Cu@Cu/C NWAs at -0.1 V vs a reversible hydrogen electrode (RHE), which are far superior to those of Cu NWAs and other reported performances under similar conditions. The construction of a porous carbon support can effectively decrease the NO diffusion kinetics and promote NO coverage for subsequent highly effective conversion. Moreover, the favorable metal-support interaction between ultrafine Cu clusters and carbon support enhances the adsorption of NO and decreases the barrier for *HNO formation in comparison with that of pure Cu NWAs. Overall, the whole NORR can be fully strengthened on Cu@Cu/C NWAs at low NO concentrations.

2.
Int J Mol Med ; 41(4): 1967-1975, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29336465

RESUMEN

Let-7 microRNAs have been reported to have tumor suppressive functions; however, the effect of Let-7 when used in combination with chemotherapies is uncertain, but may have potential for use in clinical practice. In this study, we used RT-qPCR, western blot analysis, cell proliferation assay, flow cytometry analysis, immunohistochemistry (IHC) staining, luciferase assays, cell sorting analysis and xenografted tumor model to explore the role of Let-7 in the chemotherapy sensitivity of breast cancer stem cells. The findings of the current study indicated that Let­7 enhances the effects of endocrine therapy potentially by regulating the self­renewal of cancer stem cells. Let­7c increased the anticancer functions of tamoxifen and reduced the ratio of cancer stem­like cells (CSCs), sensitizing cells to therapy-induced repression in an estrogen receptor (ER)­dependent manner. Notably, Let­7 decreased the tumor formation ability of estrogen­treated breast CSCs in vivo and suppressed Wnt signaling, which further consolidated the previously hypothesis that Let­7 decreases the self­renewal ability, contributing to reduced tumor formation ability of stem cells. The suppressive effects exerted by Let­7 on stem­like cells involved Let­7c/ER/Wnt signaling, and the functions of Let­7c exerted with tamoxifen were dependent on ER. Taken together, the findings identified a biochemical and functional link between Let­7 and endocrine therapy in breast CSCs, which may facilitate clinical treatment in the future using delivery of suppressive Let-7.


Asunto(s)
Antineoplásicos Hormonales/farmacología , Neoplasias de la Mama/tratamiento farmacológico , Autorrenovación de las Células/efectos de los fármacos , MicroARNs/genética , Células Madre Neoplásicas/efectos de los fármacos , Tamoxifeno/farmacología , Anciano , Anciano de 80 o más Años , Animales , Antineoplásicos Hormonales/uso terapéutico , Mama/efectos de los fármacos , Mama/patología , Neoplasias de la Mama/genética , Neoplasias de la Mama/patología , Femenino , Humanos , Células MCF-7 , Masculino , Ratones Desnudos , Persona de Mediana Edad , Células Madre Neoplásicas/patología , Tamoxifeno/uso terapéutico , Regulación hacia Arriba , Vía de Señalización Wnt/efectos de los fármacos
3.
Cancer Invest ; 35(10): 639-646, 2017 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-29243989

RESUMEN

To determine the most suitable strategy in treating patients with invasive breast cancer from Northwest China. Lower recurrence score (RS) correlated with lower recurrence ratio. Patients having a medium-high 21-gene RS who received adjuvant therapy presented lower recurrence risk. Younger patients having RS results (⩾31) tended to accept adjuvant therapy more often, however, those having intermediate RS results were inclined to wait and did not receive chemotherapy. These results suggested that RS-based precision medicine will allow individualized diagnosis and treatment, resulting in better outcomes and preserved medical resources.


Asunto(s)
Biomarcadores de Tumor/genética , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/genética , Perfilación de la Expresión Génica/métodos , Quimioterapia Adyuvante , China , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Medicina de Precisión , Pronóstico , Análisis de Supervivencia , Resultado del Tratamiento
4.
Exp Ther Med ; 14(3): 2584-2594, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28962198

RESUMEN

Evaluating the clinicopathological features of patients receiving definitive treatment for esophageal cancer may facilitate the identification of patterns and factors associated with post-operative complications, and enable the development of a surveillance strategy for surviving patients at a higher risk of disease recurrence. In the present study, clinical data from 579 patients with esophageal cancer that underwent radical resection of esophagus were collected. These patients were admitted to two medical centers in Northwest China, and information regarding the presence or absence of basic chronic diseases and post-operative results were retrospectively analyzed. The level of selected stem cell markers, including aldehyde dehydrogenase 1, CD133, integrin subunit α 6, integrin subunit ß 4 and T-cell factor-4, were determined in esophageal cancer tissue samples in order to determine whether these markers may be useful predictors of disease prognosis and recurrence. Post-operative complications in patients receiving radical resection of the esophagus included respiratory system complications, cardiovascular abnormalities and esophageal anastomotic fistulae. Diabetes, basic respiratory disease and lower pre-surgical serum albumin levels were observed to be individual risk factors associated with post-operative complications, including respiratory system complications of acute respiratory failure and pulmonary infection, cardiovascular abnormalities of atrial fibrillation and arrhythmia, as well as the development of esophageal anastomotic fistulae. Diagnosis of esophageal cancer at later stage was significantly correlated with anastomotic fistula. Molecular detection of stem cell markers for prognosis prediction was achieved by immunohistochemical and immunofluorescence staining assays. The results demonstrated that the presence of stem-like cells in cancer tissues was associated with poor disease prognosis and a high recurrence ratio. In conclusion, the results of the current study suggested that post-operative complications were more likely to occur in patients with diabetes, basic respiratory disease or lower serum albumin levels prior to surgery. Therefore, sufficient intensive peri-operative care, rigorous operative risk assessments, and the selection of the patients with early or mid-stage esophageal cancer, may decrease the risk of post-surgical complications in patients receiving radical resection of the esophagus. In addition, a high ratio of esophageal cancer stem-like cells was associated with cancer recurrence. These results suggest that an intensive surveillance strategy should be implemented in order to facilitate early detection of disease recurrence and improve the clinical management of these patients post-surgery.

5.
Cell Cycle ; 16(24): 2374-2385, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28949784

RESUMEN

Lung carcinoma tops the categories of cancer related motility, and has been treated as the main threat to human health. The functions and related mechanism of FBXW7 controlled lung cancer stem cells' signatures is barely unknown, and the miR-367 regulations of FBXW7 via Wnt signaling have not been explored. Cancer stem cells of either ALDH1+ or CD133+ phenotype were found to be referred to advanced stages in patients with NSCLC (non-small cell lung carcinoma). To study the roles of miR-367, we found greater miR-367 level or FBXW7 level was reserved in NSCLC than that of paired adjacent normal tissues, and their upregulations were positively correlated with Wnt signaling activation. On the contrary, increased miR-367 was correlated with Let-7 repression. MiR-367 was related to stronger sphere forming ability in stem cells of NSCLC. We then explored the functions of the endogenous miR-367 in stem-like cells isolated from NSCLC cell lines. In HEK-293 cells, we identified FBXW7 as the direct downstream gene of miR-367, which consequently released the LIN-28 dependent inhibition of suppressive Let-7. Through informatics analysis, miR-367 was predicated to function through Wnt signaling, and decreased Let-7 played the pivotal role to maintain TCF-4/Wnt pathway activity. The reintroduction of FBXW7 abolished the oncogenic stimulation of miR-367 on TCF-4 activity, with Wnt signaling factors depression. In conclusion, our findings demonstrated the oncogenic roles of miR-367 exerting on the self-renewal ability of cancer stem-like cells through degrading the suppressive FBXW7, eventually helping to maintain Wnt signaling activation through a LIN28B/Let-7 dependent manner.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/patología , Proteína 7 que Contiene Repeticiones F-Box-WD/metabolismo , Neoplasias Pulmonares/patología , MicroARNs/metabolismo , Vía de Señalización Wnt , Regiones no Traducidas 3' , Antagomirs/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/mortalidad , Línea Celular Tumoral , Proteína 7 que Contiene Repeticiones F-Box-WD/química , Proteína 7 que Contiene Repeticiones F-Box-WD/genética , Femenino , Células HEK293 , Humanos , Estimación de Kaplan-Meier , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/mortalidad , Masculino , MicroARNs/antagonistas & inhibidores , MicroARNs/genética , Persona de Mediana Edad , Células Madre Neoplásicas/metabolismo , Pronóstico , Factor de Transcripción 4/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA